Pharmacosmos initiates phase III clinical trial of trilaciclib in limited-stage small cell lung cancer MORRISTOWN, NJ, ...
The Tiny Cargo Company ("Tiny Cargo") and Bio-Sourcing SA (‘Bio-Sourcing’) today announced a strategic partnership to develop ...
This episode, titled Optimizing Subcutaneous Therapies in NSCLC: Practical Integration, Patient Selection, and Workflow ...
Fred D. Lublin, MD, discusses therapy sequencing, deescalation, health equity, and the future of multiple sclerosis (MS) care delivery. Effective multiple sclerosis (MS) treatment requires thinking ...
After a career spanning two decades at Bear Stearns, Lehman Brothers, and Morgan Stanley, I gained an institutional ...
Bangladesh’s banking sector, a pillar of its growing economy, faces structural fragility. Several banks operate ...
For years, one of the most powerful weapons against certain blood cancers, called CAR-T cell therapy, has required an ...
MiniMed (Nasdaq: MMED), a global leader in diabetes technology, today announced U.S. Food and Drug Administration (FDA) clearance of MiniMed Flex™, a next-generation discreet, smartphone-controlled ...
Candidates Bridget McCandless and Kevin King have both generally expressed support for the $150 billion AI data center coming ...
Morning Overview on MSN
Single mRNA-like shot helped heart muscle heal after attacks in animals
Scientists have shown that a single injection of self-amplifying RNA, delivered into skeletal muscle rather than the heart ...
My dog has cancer. Not for the first time. Nor the second or third time. But for the fourth time in three years. Unlike an ...
For years, one of the most powerful weapons against certain blood cancers, called CAR-T cell therapy, has required an elaborate process: Doctors ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results